Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycin

Anticancer Res. 1989 Nov-Dec;9(6):1835-40.

Abstract

Inhibitors of protein synthesis may modify cell response to cytotoxic drugs. The influence of protein synthesis inhibition using sparsomycin (Sm) on the cytotoxicity of seven classical cytotoxic drugs, 5-FU, ARA-C, MTX, doxorubicin, melphalan, bleomycin and vincristine, was studied. Preincubations, simultaneous incubations and postincubations with Sm were investigated in vitro on CHO cells. Preincubation with Sm antagonized the activity of the S phase specific drugs 5-FU, ARA-C, MTX as well as vincristine, while postincubation with Sm enhanced their effect. A similar pattern was observed with doxorubicin. Preincubation with Sm had a potentiated non-S phase specific like bleomycin and cisplatin, but not melphalan. Postincubation with Sm had a potentiating effect on bleomycin but had no effect on melphalan. These results indicate a strong, schedule dependent effect of Sm on various drugs and suggest some potentially useful combinations to be tested in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Pharmaceutic / pharmacology
  • Animals
  • Antibiotics, Antineoplastic / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Bleomycin / pharmacology
  • Cell Line
  • Cell Survival / drug effects*
  • Cisplatin / pharmacology
  • Cytarabine / pharmacology
  • Doxorubicin / pharmacology
  • Fluorouracil / pharmacology
  • Melphalan / pharmacology
  • Methotrexate / pharmacology
  • Protein Synthesis Inhibitors*
  • Sparsomycin / pharmacology*
  • Vincristine / pharmacology

Substances

  • Adjuvants, Pharmaceutic
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Protein Synthesis Inhibitors
  • Cytarabine
  • Bleomycin
  • Vincristine
  • Sparsomycin
  • Doxorubicin
  • Cisplatin
  • Melphalan
  • Fluorouracil
  • Methotrexate